103 related articles for article (PubMed ID: 1399954)
1. In-vitro activity of RP 59500, a new synergic antibacterial agent, against Legionella spp.
Dubois J; Joly JR
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():77-81. PubMed ID: 1399954
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of gatifloxacin, compared with ciprofloxacin, clarithromycin, erythromycin, and rifampin, against Legionella species.
Dubois J; St-Pierre C
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):261-5. PubMed ID: 10212753
[TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of a new oral streptogramin, RPR 106972, alone and in combination with rifampicin or ciprofloxacin against Legionella spp.
Pendland SL; Killian AD; Woodward JG; Rodvold KA
J Antimicrob Chemother; 1997 May; 39(5):651-3. PubMed ID: 9184367
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of lomefloxacin (SC 47111 or NY-198) against isolates of Legionella spp.
Dubois J; Joly JR
Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):89S-91S. PubMed ID: 2791504
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of RP 74501-RP 74502, a novel streptogramin antimicrobial mixture, against clinical isolates of Legionella species.
Edelstein PH; Edelstein MA
Antimicrob Agents Chemother; 1993 Apr; 37(4):908-10. PubMed ID: 8494390
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
Dubois J; St-Pierre C
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Legionella species to five antibiotics and development of resistance by exposure to erythromycin, ciprofloxacin, and rifampicin.
Nielsen K; Bangsborg JM; Høiby N
Diagn Microbiol Infect Dis; 2000 Jan; 36(1):43-8. PubMed ID: 10744366
[TBL] [Abstract][Full Text] [Related]
8. Sensitivity and resistance of Legionella pneumophila to some antibiotics and combinations of antibiotics.
Moffie BG; Mouton RP
J Antimicrob Chemother; 1988 Oct; 22(4):457-62. PubMed ID: 3204075
[TBL] [Abstract][Full Text] [Related]
9. Lack of resistance to erythromycin, rifampicin and ciprofloxacin in 98 clinical isolates of Legionella pneumophila.
Onody C; Matsiota-Bernard P; Nauciel C
J Antimicrob Chemother; 1997 Jun; 39(6):815-6. PubMed ID: 9222053
[TBL] [Abstract][Full Text] [Related]
10. The effects of single and combined antibiotics on the growth of Legionella pneumophila using time-kill studies.
Barker JE; Farrell ID
J Antimicrob Chemother; 1990 Jul; 26(1):45-53. PubMed ID: 2211446
[TBL] [Abstract][Full Text] [Related]
11. The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination.
Neu HC; Chin NX; Gu JW
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():83-94. PubMed ID: 1328138
[TBL] [Abstract][Full Text] [Related]
12. The in-vitro activity of moxifloxacin against Legionella species and the effects of medium on susceptibility test results.
Ruckdeschel G; Dalhoff A
J Antimicrob Chemother; 1999 May; 43 Suppl B():25-9. PubMed ID: 10382872
[TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activity of RP 59500.
Verbist L; Verhaegen J
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():39-44. PubMed ID: 1399949
[TBL] [Abstract][Full Text] [Related]
14. In-vitro activity of RP 59500, a new semisynthetic streptogramin antibiotic, against gram-positive bacteria.
Brumfitt W; Hamilton-Miller JM; Shah S
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():29-37. PubMed ID: 1399948
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
Pohlod DJ; Saravolatz LD; Somerville MM
J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
[TBL] [Abstract][Full Text] [Related]
16. [Practical problems raised by antibiotic minimal inhibitory concentration determination in Legionella species (author's transl)].
Bornstein N; Roudier C; Fleurette J
Pathol Biol (Paris); 1982 Jun; 30(6):421-5. PubMed ID: 6810285
[TBL] [Abstract][Full Text] [Related]
17. Activity of azithromycin, clarithromycin, roxithromycin, dirithromycin, quinupristin/dalfopristin and erythromycin against Legionella species by intracellular susceptibility testing in HL-60 cells.
Stout JE; Arnold B; Yu VL
J Antimicrob Chemother; 1998 Feb; 41(2):289-91. PubMed ID: 9533475
[TBL] [Abstract][Full Text] [Related]
18. In-vitro antibacterial activity of RP 59500, a semisynthetic streptogramin, against Streptococcus pneumoniae.
Fremaux A; Sissia G; Cohen R; Geslin P
J Antimicrob Chemother; 1992 Jul; 30 Suppl A():19-23. PubMed ID: 1399946
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species.
Dubois J; St-Pierre C
Clin Microbiol Infect; 1999 Apr; 5(4):205-212. PubMed ID: 11856251
[TBL] [Abstract][Full Text] [Related]
20. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ
J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
